%0 Journal Article
%T Ceftolozane-Tazobactam for the Treatment of Multidrug-Resistant Pseudomonas aeruginosa Infections: A Multicenter Study
%A Abdulrahman Elabor
%A Bruce M Jones
%A Christopher M Bland
%A Claudine El-Beyrouty
%A Daohai Yu
%A Deepali Dixit
%A Dorothy McCoy
%A Emily L Heil
%A Erin K McCreary
%A Esther Molnar
%A Jason C Gallagher
%A Jin Suh
%A Jon Hiles
%A Kenneth Biason
%A Kimberly C Claeys
%A Lynette Richards
%A Madeline A King
%A Michael J Satlin
%A Nicole Harrington
%A Nidhi Saraiya
%A Nikunj M Vyas
%A Saira Chaudhry
%A Xiaoning Lu
%A Yi Guo
%J Archive of "Open Forum Infectious Diseases".
%D 2018
%R 10.1093/ofid/ofy280
%X Multidrug-resistant Pseudomonas aeruginosa infections remain common in hospitals worldwide. We investigated the outcomes associated with the use of ceftolozane-tazobactam for the treatment of these infections
%K ceftolozane-tazobactam
%K Gram-negative
%K multidrug-resistant infections
%K Pseudomonas
%K resistance
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6247659/